About Us Company Profile

BGI Oncology

At BGI Oncology, we are dedicated to our mission of "Omics for All". Relying on our own sequencing platform, as well as accurate data and algorithms, we have developed a complete line of genetic testing with a focus on cancer prevention, early identification, diagnosis, treatment, and recurrence monitoring for cancer patients, and a platform for new drug development and complementary diagnostics for the pharmaceutical industry.

BGI Oncology is particularly superior in gynecologic oncology. In addition to the introduction of BRCA gene testing and the homologous recombination deficiency (HRD) score, we've participated in the formulation and interpretation of multiple expert consensus standards for BRCA testing, and cooperated on concomitant testing with large oncology drug development companies to promote the clinical application of genetic testing technologies in the diagnosis and treatment of gynecologic cancers.
BGI's Global Distribution

Customer Service:

+1 866 301 0097

Service Time:7*24



Copyright © BGI 2022. All Rights Reserved. Guangdong ICP Registration No. 16021117